Last reviewed · How we verify
NCT04331938
Efficacy of Percutaneous SPG Block in Aneurysmal SAH
Phase 1 trial testing Regional anesthetic SPG block-bilateral in Subarachnoid Hemorrhage in 2 participants. Completed in 8 April 2024.
8 April 2024
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2 |
| Start date | 1 November 2020 |
| Primary completion | 8 April 2024 |
| Estimated completion | 8 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Regional anesthetic SPG block-bilateral — full drug profile →
Conditions studied
- Subarachnoid Hemorrhage — all drugs for Subarachnoid Hemorrhage →
- Headache — all drugs for Headache →
Sponsor
Mayo Clinic
Who can join
18 and older, any sex, with Subarachnoid Hemorrhage or Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers are trying to develop alternative means to help patients with headache pain secondary to aneurysmal subarachnoid hemorrhage (bleeding about the brain).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04331938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subarachnoid Hemorrhage
Currently open trials in the same condition.
- NCT06797765 — Optical Coherence Tomography Angiography in Neurological Disease · recruiting
- NCT06866210 — Risk Analysis of Intracranial Aneurysm Rupture Through Social Determinants of Health · active not recruiting
- NCT06797752 — Effect of the Stellate Ganglion Block on the Retinal Microcirculation · recruiting
- NCT06192342 — Ventilatory Parameters in Acute Neurological Injury · recruiting
- NCT04459806 — Intracranial PrEssure Time dOse (ImPETO) · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04331938 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 9 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04331938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing